Conference on Photodynamic Therapy

光动力疗法会议

• 批准号: 6503747
• 负责人: David Harry Kessel
• 金额: $ 0.5万
• 依托单位: WAYNE STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-11 至 2003-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6503747
• 关键词: cell death; meeting /conference /symposium; neoplasm /cancer photoradiation therapy; travel

DESCRIPTION (provided by applicant): This proposal requests support for a Symposium on recent developments in Photodynamic Therapy, to be held in conjunction with the 2002 meeting of the American Society for Photobiology in Quebec City, Canada. An organizing committee has been identified, and the meeting will be able to take advantage of the ASP facilities with regard to hotel selection, announcements and mechanisms for dealing with proffered papers and poster proposals. Since there is no other major PDT conference in 2002, this will be an opportunity for workers in the field to receive updates on research from major laboratories and exchange additional information. The meeting will concentrate on: mechanisms of cell death, cellular responses to PDT and photosensitized inactivation of molecular targets. This will encompass the three modes of cell death but also include some of the newer work on induction of cytokines and the use of PDT to approach some of the molecular targets (e.g., growth factor receptors and PKC). The typical registration for ASP meetings is 350-400, but the addition of a substantial PDT symposium is expected to attract additional participants. The most recent PDT meeting, sponsored by the International Photodynamic Assn, has more than 600 participants.

描述(由申请人提供)： 这项提议请求支持将与2002年在加拿大魁北克市举行的美国光生物学学会会议一起举行的关于光动力疗法最新发展的研讨会。已经确定了一个组织委员会，会议将能够在酒店选择、公告和处理提交的文件和海报提案的机制方面利用ASP设施。 由于2002年没有其他重要的PDT会议，这将是该领域的工作人员获得主要实验室研究的最新情况和交流更多信息的机会。会议将集中讨论：细胞死亡的机制，细胞对PDT的反应和分子靶标的光敏失活。这将包括三种细胞死亡模式，但也包括一些最新的工作，诱导细胞因子和使用PDT接近一些分子靶点(例如，生长因子受体和PKC)。 ASP会议的典型注册人数为350-400人，但增加一个实质性的PDT研讨会预计将吸引更多的参与者。最近的一次PDT会议由国际光动力学协会主办，有600多人参加。